Abstract
Reductions in tuberculosis (TB) incidence and mortality require identification of individuals at high risk of developing active disease, such as those with recent Mycobacterium tuberculosis (Mtb) infection. Current tests used for Mtb infection cannot distinguish recent from remote infection. Using a longitudinal, prospective household contact (HHC) study in Kampala, Uganda, we diagnosed new Mtb infection using both the tuberculin skin test (TST) and interferon-gamma release assay (IGRA) to determine if these tests differentiated or added value as measures of recent Mtb infection. We identified 13 HHCs who only converted the IGRA (QFT-only converters), 39 HHCs who only converted the TST (TST-only converters), and 24 HHCs who converted both tests (QFT/TST converters). Univariate analysis revealed that TST-only converters were older than the other groups. This result was confirmed by our logistic regression model where increased odds of TST-only conversion was associated with age (p=0.02), in addition to crowdedness (p=0.025). The odds of QFT conversion increased with a higher epidemiologic risk score (p=0.038), which suggests it is a better measure of Mtb exposure and infection. QFT/TST converters had higher QFT quantitative values at conversion than QFT-only converters and a bigger change in TST quantitative values at conversion than TST-only converters. Collectively, these data indicate that TST conversion alone likely overestimates Mtb infection. Its correlation to older age suggests boosting of BCG responses and/or longer environmental mycobacterial exposure. This result also suggests that QFT/TST conversion may be associated with a more robust immune response, which should be considered when planning vaccine studies.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding for this work was provided by T32HL007567 (JG, CMS), R01AI157807 (CMS), U19AI162583 (WHB), BAA-NIAID-NIHAI201700104 (WHB), and RO1AI147319 (CMB, JG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocol was reviewed and approved by The Uganda National Council on Science and Technology, and the institutional review board at the University Hospitals Cleveland Medical Center. Written consent was obtained from all participants ages 18 and older. Assent was obtained prior to screening from individuals ages 15 to 17, as well as informed consent from their parent or guardian.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Data Availability
Data cannot be shared because of constraints by the Ugandan institutional review boards. Data are available by applying to a data access committee chaired by Dr. Sudha Iyengar (ski@case.edu) and application to Ugandan institution review board
